Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 OutpatientsObservational Study Published on 2023-05-012023-07-10 Journal: Chest [Category] COVID19(2023년), [키워드] COVID-19 delta variant Hospitalization mechanical ventilation monoclonal antibody Outpatient. [DOI] 10.1016/j.chest.2022.10.020 PMC 바로가기 [Article Type] Observational Study
Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivoArticle Published on 2023-04-012023-07-11 Journal: Virologica Sinica [Category] COVID19(2023년), [키워드] B.1.351 B.1.617.2 COVID-19 monoclonal antibody SARS-CoV-2. [DOI] 10.1016/j.virs.2022.12.007 PMC 바로가기
Monoclonal antibody targeting a novel linear epitope on nucleoprotein confers pan-reactivity to influenza A virusArticle Published on 2023-04-012023-06-23 Journal: Applied Microbiology and Biotechnology [Category] 신종인플루엔자, [키워드] Influenza virus linear B-cell epitope monoclonal antibody nucleoprotein Universal reactivity. [DOI] 10.1007/s00253-023-12433-3 PMC 바로가기
Monoclonal antibody designed for SARS-nCoV-2 spike protein of receptor binding domain on antigenic targeted epitopes for inhibition to prevent viral entryArticle Published on 2023-04-012023-07-09 Journal: Molecular diversity [Category] COVID19(2023년), [키워드] cellular immune responses COVID19 Human receptor angiotensin converting enzyme-2 (hACE2) monoclonal antibody receptor binding domain (RBD) Severe acute respiratory syndrome-coronavirus (SARS-CoV-2) spike (S) protein. [DOI] 10.1007/s11030-022-10449-x PMC 바로가기
Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phaseObservational Study Published on 2023-03-012023-07-10 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] COVID-19 monoclonal antibody real-world evidence. [DOI] 10.1016/j.ijid.2022.10.002 PMC 바로가기 [Article Type] Observational Study
Inhalable neutralizing antibodies – promising approach to combating respiratory viral infectionsReview Published on 2023-02-012023-07-11 Journal: Trends in pharmacological sciences [Category] COVID19(2023년), [키워드] COVID-19 engineered antibody intranasal delivery monoclonal antibody pulmonary delivery. SARS-CoV-2 [DOI] 10.1016/j.tips.2022.11.006 PMC 바로가기 [Article Type] Review
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysisMeta-Analysis Published on 2023-02-012023-07-08 Journal: Infection [Category] COVID19(2023년), [키워드] antibody convalescent plasma monoclonal antibody Network meta-analysis SARS-CoV-2. [DOI] 10.1007/s15010-022-01825-8 PMC 바로가기 [Article Type] Meta-Analysis
Reply to “successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients-A Czech multicenter experience”: A case series of SARS-CoV-2 Omicron infection and aggressive lymphoma in the Sotrovimab eraMulticenter Study Published on 2023-02-012023-07-10 Journal: Hematological oncology [Category] COVID19(2023년), [키워드] aggressive lymphoma monoclonal antibody Omicron. SARS-CoV-2 [DOI] 10.1002/hon.3079 PMC 바로가기 [Article Type] Multicenter Study
In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeysArticle Published on 2023-02-012023-07-10 Journal: European Journal of Nuclear Medicine and Molecular [Category] COVID19(2023년), [키워드] 89Zr-PET biodistribution monoclonal antibody Physiologically based pharmacokinetics (PBPK) Radiomics respiratory tract SARS-CoV-2 Sotrovimab. [DOI] 10.1007/s00259-022-06012-3 PMC 바로가기
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19Article Published on 2023-01-242023-07-11 Journal: Antimicrobial Agents and Chemotherapy [Category] COVID19(2023년), [키워드] ADG20 adintrevimab animal model COVID-19 monoclonal antibody Preclinical prevention. SARS-CoV-2 [DOI] 10.1128/aac.01353-22 PMC 바로가기